Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
ETFs with exposure to Bio-Rad Laboratories, Inc. (BIO)
First Trust Health Care AlphaDEX Fund ETF - USD This ETF provides exposure to Other Large Cap US Health Care Equities | 2.33% | +6.91% | +7.82% | +€26M | -€37M | €843M | 0.61% | |
|---|---|---|---|---|---|---|---|---|
First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD Hedged This ETF provides exposure to Other Large Cap US Health Care Equities | 2.33% | +6.45% | +6.36% | €0 | €0 | €2M | 0.76% | Not rated |
First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD This ETF provides exposure to Other Large Cap US Health Care Equities | 2.33% | +9.23% | +10.95% | +€869 | -€1.3M | €2.9M | 0.76% | |
First Trust Indxx Medical Devices ETF - USD This ETF provides exposure to Equally Weighted Equities | 2.24% | +2.44% | -8.61% | €0 | €0 | €1.7M | 0.7% | |
L&G Healthcare Technology & Innovation UCITS ETF - USD This ETF provides exposure to Other Equities | 1.70% | +9.77% | +7.03% | +€30M | +€34M | €234M | 0.49% | |
Robo Global Healthcare Technology and Innovation ETF - USD This ETF provides exposure to Other Equities | 1.70% | +9.76% | +6.94% | -€7.8K | +€2.9M | €53M | 0.8% | |
1.19% | +5.84% | +16.08% | €0 | -€1.9M | €23M | 0.59% | Not rated | |
1.00% | -2.54% | +6.57% | +€115M | +€959M | €1.78B | 0.79% | Not rated | |
0.82% | +8.42% | +6.98% | +€18M | +€7.4M | €982M | 0.4% | ||
0.82% | +11.81% | +7.71% | +€869 | -€418K | €13M | 0.75% | Not rated | |
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
